Reduction of reinfarction and angina with use of low-molecular-weight heparin therapy after streptokinase (and heparin) in acute myocardial infarction
Authors:
- 1 June 1996
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 77 (14) , 1145-1148
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Persistent activation of coagulation mechanism in unstable angina and myocardial infarction.Circulation, 1994
- Reactivation of Unstable Angina after the Discontinuation of HeparinNew England Journal of Medicine, 1992
- Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II.Circulation, 1992
- Low molecular weight heparinBlood, 1992
- Effect of coronary reocclusion after initial reperfusion on ventricular function and infarct sizeJACC, 1991
- Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group.Circulation, 1990
- Guidelines for the early management of patients with acute myocardial infarctionJACC, 1990
- Platelets and Thrombolytic TherapyNew England Journal of Medicine, 1990
- Thrombolysis and Angioplasty in Myocardial Infarction (TAMI-1) trial: Influence of infarct location on arterial patency, left ventricular function and mortalityJACC, 1989
- The ischemic risk syndrome following thrombolysisCurrent Opinion in Cardiology, 1988